Literature DB >> 32043146

Blinatumomab for infant acute lymphoblastic leukemia.

Katherine Clesham1, Vasudha Rao1, Jack Bartram1, Philip Ancliff1, Sara Ghorashian1, David O'Connor1,2, Vesna Pavasovic1, Anupama Rao1, Sujith Samarasinghe1, Michelle Cummins3, Andrea Malone4, Katharine Patrick5, Denise Bonney6, Beki James7, Brenda Gibson8, Ajay Vora1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32043146     DOI： 10.1182/blood.2019004008

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era.

Authors:  Shang Mengxuan; Zhou Fen; Jin Runming
Journal:  Front Pediatr       Date:  2022-06-23       Impact factor: 3.569

2.  Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.

Authors:  Benoît Brethon; Elodie Lainey; Aurélie Caye-Eude; Audrey Grain; Odile Fenneteau; Karima Yakouben; Julie Roupret-Serzec; Lou Le Mouel; Hélène Cavé; André Baruchel
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

3.  Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene-rearranged acute lymphoblastic leukemia.

Authors:  Takayuki Takachi; Tomoyuki Watanabe; Takako Miyamura; Akiko Moriya Saito; Takao Deguchi; Toshinori Hori; Tomomi Yamada; Shigeru Ohmori; Masami Haba; Yuki Aoki; Sae Ishimaru; Shinya Sasaki; Junjiro Ohshima; Akihiro Iguchi; Yoshiyuki Takahashi; Nobuyuki Hyakuna; Atsushi Manabe; Keizo Horibe; Eiichi Ishii; Katsuyoshi Koh; Daisuke Tomizawa
Journal:  Blood Adv       Date:  2021-10-12

4.  Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia.

Authors:  Jae Wook Lee; Seongkoo Kim; Pil-Sang Jang; Nack-Gyun Chung; Bin Cho
Journal:  Cancer Res Treat       Date:  2020-10-08       Impact factor: 4.679

5.  Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia.

Authors:  Laurence C Cheung; Rebecca de Kraa; Joyce Oommen; Grace-Alyssa Chua; Sajla Singh; Anastasia M Hughes; Emanuela Ferrari; Jette Ford; Sung K Chiu; Ronald W Stam; Ursula R Kees; Sébastien Malinge; Rishi S Kotecha
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

Review 6.  Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL?

Authors:  Krisztián Miklós Kállay; Mattia Algeri; Jochen Buechner; Aviva C Krauss
Journal:  Front Pediatr       Date:  2022-02-02       Impact factor: 3.418

Review 7.  Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond.

Authors:  Adriana Balduzzi; Jochen Buechner; Marianne Ifversen; Jean-Hugues Dalle; Anca M Colita; Marc Bierings
Journal:  Front Pediatr       Date:  2022-02-24       Impact factor: 3.418

8.  Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.

Authors:  Alexandra Semchenkova; Ekaterina Mikhailova; Alexander Komkov; Marina Gaskova; Ruslan Abasov; Evgenii Matveev; Marat Kazanov; Ilgar Mamedov; Anna Shmitko; Vera Belova; Anna Miroshnichenkova; Olga Illarionova; Yulia Olshanskaya; Grigory Tsaur; Tatiana Verzhbitskaya; Natalia Ponomareva; Gleb Bronin; Konstantin Kondratchik; Larisa Fechina; Yulia Diakonova; Liudmila Vavilova; Natalia Myakova; Galina Novichkova; Alexey Maschan; Michael Maschan; Elena Zerkalenkova; Alexander Popov
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.